These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. Costantino CM; Gupta A; Yewdall AW; Dale BM; Devi LA; Chen BK PLoS One; 2012; 7(3):e33961. PubMed ID: 22448282 [TBL] [Abstract][Full Text] [Related]
66. Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. Rozenfeld R; Bushlin I; Gomes I; Tzavaras N; Gupta A; Neves S; Battini L; Gusella GL; Lachmann A; Ma'ayan A; Blitzer RD; Devi LA PLoS One; 2012; 7(1):e29239. PubMed ID: 22235275 [TBL] [Abstract][Full Text] [Related]
67. Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology. Stockton SD; Devi LA Drug Alcohol Depend; 2012 Mar; 121(3):167-72. PubMed ID: 22115888 [TBL] [Abstract][Full Text] [Related]
68. Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord. Miller LK; Hou X; Rodriguiz RM; Gagnidze K; Sweedler JV; Wetsel WC; Devi LA J Neurochem; 2011 Dec; 119(5):1074-85. PubMed ID: 21972895 [TBL] [Abstract][Full Text] [Related]
69. Potentiation of μ-opioid receptor-mediated signaling by ketamine. Gupta A; Devi LA; Gomes I J Neurochem; 2011 Oct; 119(2):294-302. PubMed ID: 21692801 [TBL] [Abstract][Full Text] [Related]
70. G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding. Gomes I; Ijzerman AP; Ye K; Maillet EL; Devi LA Mol Pharmacol; 2011 Jun; 79(6):1044-52. PubMed ID: 21415307 [TBL] [Abstract][Full Text] [Related]
71. β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. LaRocca TJ; Schwarzkopf M; Altman P; Zhang S; Gupta A; Gomes I; Alvin Z; Champion HC; Haddad G; Hajjar RJ; Devi LA; Schecter AD; Tarzami ST J Cardiovasc Pharmacol; 2010 Nov; 56(5):548-59. PubMed ID: 20729750 [TBL] [Abstract][Full Text] [Related]
72. Increased abundance of opioid receptor heteromers after chronic morphine administration. Gupta A; Mulder J; Gomes I; Rozenfeld R; Bushlin I; Ong E; Lim M; Maillet E; Junek M; Cahill CM; Harkany T; Devi LA Sci Signal; 2010 Jul; 3(131):ra54. PubMed ID: 20647592 [TBL] [Abstract][Full Text] [Related]
73. Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor. Tao PL; Law PY; Loh HH IUBMB Life; 2010 Feb; 62(2):103-11. PubMed ID: 20039371 [TBL] [Abstract][Full Text] [Related]
75. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Heimann AS; Gomes I; Dale CS; Pagano RL; Gupta A; de Souza LL; Luchessi AD; Castro LM; Giorgi R; Rioli V; Ferro ES; Devi LA Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20588-93. PubMed ID: 18077343 [TBL] [Abstract][Full Text] [Related]
76. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Gomes I; Gupta A; Filipovska J; Szeto HH; Pintar JE; Devi LA Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5135-9. PubMed ID: 15044695 [TBL] [Abstract][Full Text] [Related]
77. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Gomes I; Filipovska J; Devi LA Methods Mol Med; 2003; 84():157-83. PubMed ID: 12703323 [No Abstract] [Full Text] [Related]
78. Analysis of function of receptor-G-protein and receptor-RGS fusion proteins. Ward RJ; Milligan G Methods Mol Biol; 2004; 259():225-47. PubMed ID: 15250496 [TBL] [Abstract][Full Text] [Related]